Dangerous Side Effects - Watch These Videos Before Use

Home

Dangerous Side Effects

All Time

Today

This week

This month

This year

What is Ramipril?| Ramipril and High Blood Pressure | What are the side effects of taking Ramipril? Side Effects 2 Views • 2 months ago

What is Ramipril? Facts about Ramipril, high blood pressure and what a healthy salt intake looks like.

Hello viewers and welcome to Never Miss a Dose, Echo’s weekly look inside the medicine cabinet of the nation. In this series, we’ll take a look at the most commonly prescribed medicines the UK, what they’re used to treat and how best to take them. We’ll also do a demonstration at the end of each episode - it’s worth waiting for!

We’re now up to our fourth episode in our six-part series on the UK’s 6 of the most common medicines on long term repeat prescription. This week our Chief Pharmacist, Alistair Murray gives us a brief rundown on the key facts about ramipril, how it’s used to treat high blood pressure as well a demonstration on what the NHS guidelines on daily, weekly and yearly salt intake really looks like - it’s quite eye-opening. 👀👀

Today we’ll answer:
*What ramipril is
*What ramipril is most commonly used to treat
*Possible side effects of taking ramipril
*When and how to take ramipril
*What the NHS guidelines for salt look like

For more information on ramipril, including the facts on ramipril and bananas, and ramipril and alcohol, check out Alistair’s blog post here: https://www.echo.co.uk/blog/what-is-ramipril

See you next week!
Echo Pharmacy

Get in touch
If there’s anything you’d like us to cover, or if you’ve any thoughts on our video or questions for Alistair, please pop a comment in the box below and we’ll get right back to you.

Please share this video with family, friends and anyone you feel that needs to learn a little more about ramipril, heart health or who needs to see what a year’s worth of salt looks like.

Subscribe to our channel for more videos- https://www.youtube.com/channel/

Hungry for more? Bring on the links!

If you’d like more information on ramipril and high blood pressure, we always recommend checking out the NHS website:

https://www.nhs.uk/medicines/ramipril/
https://www.nhs.uk/conditions/....high-blood-pressure-
https://www.nhs.uk/conditions/....high-blood-pressure-prevention/

If you’d like to learn a little more on how to maintain a healthy weight or make some improvements to your diet, the NHS is on hand to help with a wealth of information:

https://www.nhs.uk/live-well/eat-well/
https://www.nhs.uk/live-well/healthy-weight/

If you’d like to learn a little more about salt and what a healthy salt intake looks like, again we recommend checking out the NHS website:

https://www.nhs.uk/live-well/eat-well/salt-nutrition

Lastly, if you’d like to learn more about high blood pressure, we recommend checking out the British Heart Foundation:
https://www.bhf.org.uk/informa....tionsupport/risk-fac

Let’s keep in touch:
https://www.facebook.com/echo.healthcare/
https://twitter.com/echo_healthcare
https://www.instagram.com/echo_healthcare/
https://www.linkedin.com/compa....ny/echo-healthcare-u
https://www.echo.co.uk/

Who is Alistair?

Alistair Murray - MRPharmS
Chief Pharmacist- Echo Pharmacy

Alistair is a seasoned healthcare professional with over 20 years' experience working with community and digital pharmacy, third-level education and the NHS. He completed his pharmacy training at Boots and spent 15 years as a pharmacist working in community pharmacies and GP surgeries before joining the founding team of Echo in 2015. He is an honorary lecturer at UCL and the University of Nottingham, the latter where he received his masters in pharmacy.

Alistair is passionate about adherence and making sure that people are making informed choices when it comes to their health.

With a penchant for fancy dress, Alistair can also be found explaining the world of pharmacy and tweeting at https://twitter.com/murristair

Disclaimer:
This video is for informational use only and should not be used for the diagnosis or treatment of medical conditions. Echo Pharmacy has used all reasonable care in compiling the information but make no warranty as to its accuracy. Always consult your GP, a doctor or other healthcare professional for diagnosis and treatment of medical conditions.

Rosuvastatin: Uses, Side Effects, Mechanism of Action, Dosage, Warnings Side Effects 2 Views • 2 months ago

Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL Duration of Action With Dr Gavin Side Effects 2 Views • 1 month ago

Please click here https://bit.ly/3kWYNwG, or scroll below to see Important Safety Information. Please see the Prescribing Information for Tresiba® at https://bit.ly/3JEzfPg

Hear about the pharmacokinetics behind the duration of action of Tresiba® from past president of Morehouse College School of Medicine and renowned diabetes expert Dr James R Gavin, III.

For more information about the duration of action of Tresiba® visit the Tresiba® Pro website – https://bit.ly/3RyvOeH

Indications and Usage
Tresiba® (insulin degludec) injection is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.

Limitations of Use
Tresiba® is not recommended for treating diabetic ketoacidosis.

Important Safety Information

Contraindications
• Tresiba® is contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to insulin degludec or any of the excipients in Tresiba®

Warnings and Precautions
• Never Share a Tresiba® FlexTouch® Pen, Needle, or Syringe Between Patients, even if the needle is changed. Patients using Tresiba® vials should never share needles or syringes with another person. Sharing poses a risk for transmission of blood-borne pathogens.
• Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen: Changes in an insulin regimen (e.g., insulin strength, manufacturer, type, or injection site or method of administration) may affect glycemic control and predispose to hypoglycemia or hyperglycemia. Repeated insulin injections into areas of lipodystrophy or localized cutaneous amyloidosis have been reported to result in hyperglycemia; and a sudden change in the injection site (to an unaffected area) has been reported to result in hypoglycemia. Make any changes to a patient’s insulin regimen under close medical supervision with increased frequency of blood glucose monitoring. Advise patients who have repeatedly injected into areas of lipodystrophy or localized cutaneous amyloidosis to change the injection site to unaffected areas and closely monitor for hypoglycemia. Adjustments in concomitant anti-diabetic treatment may be needed.
• Hypoglycemia: Hypoglycemia is the most common adverse reaction of insulin, including Tresiba®. Severe hypoglycemia can cause seizures, may be life-threatening or cause death. Hypoglycemia can impair concentration ability and reaction time; this may place the patient and others at risk in situations where these abilities are important (e.g., driving or operating other machinery). Hypoglycemia can happen suddenly and symptoms may differ in each patient and change over time in the same patient. Symptomatic awareness of hypoglycemia may be less pronounced in patients with longstanding diabetes, in patients with diabetic neuropathy, using drugs that block the sympathetic nervous system (e.g., beta-blockers) or who experience recurrent hypoglycemia. The long-acting effect of Tresiba® may delay recovery from hypoglycemia compared to shorter-acting insulins.
Risk Factors for Hypoglycemia: The risk of hypoglycemia generally increases with intensity of glycemic control. The risk of hypoglycemia after an injection is related to the duration of action of the insulin and, in general, is highest when the glucose lowering effect of the insulin is maximal. As with all insulins, the glucose lowering effect time course of Tresiba® may vary among different patients or at different times in the same patients and depends on many conditions, including the area of injection as well as the injection site blood supply and temperature. Other factors which may increase the risk of hypoglycemia include changes in meal pattern, changes in level of physical activity, or changes to concomitant drugs. Patients with renal or hepatic impairment may be at higher risk of hypoglycemia. Patients and caregivers must be educated to recognize and manage hypoglycemia. In patients at higher risk for hypoglycemia and patients who have reduced symptomatic awareness of hypoglycemia, increased frequency of blood glucose monitoring is recommended.
• Hypoglycemia Due to Medication Errors: Accidental mix-ups between insulin products have been reported. To avoid medication errors between Tresiba® and other insulins, always instruct patients to always check the insulin label before each injection. To avoid dosing errors and potential overdose, never use a syringe to remove Tresiba® from the Tresiba® FlexTouch® disposable insulin prefilled pen.
• Hypersensitivity Reactions: Severe, life-threatening, generalized allergy, including anaphylaxis, can occur with insulins, including Tresiba®. If hypersensitivity reactions occur, discontinue Tresiba®; treat per standard of care and monitor until symptoms and signs resolve.

Click here: https://bit.ly/3kWYNwG, or see video above for additional Important Safety information.